Core Insights - Zoetis Inc. reported a third-quarter 2025 adjusted earnings per share of $1.70, surpassing the consensus estimate of $1.62 [1] - The company reaffirmed its 2025 adjusted earnings guidance of $6.30-$6.40 per share, slightly above the consensus of $6.35 [2] - Sales for the quarter were $2.4 billion, reflecting a 1% year-over-year increase but falling short of the consensus estimate of $2.41 billion [4] Financial Performance - Adjusted net income for the quarter was $754 million, marking a 5% increase on a reported basis and a 9% rise on an organic operational basis [1] - The company updated its full-year 2025 sales guidance, lowering it from $9.45 billion-$9.60 billion to $9.4 billion-$9.475 billion, compared to the consensus of $9.52 billion [4] - Organic operational growth expectations were revised down from 6.5%-8.0% to 5.5%-6.5% [4] Market and Competitive Landscape - Companion animal organic growth was reported at 2%, which is below expectations and one of the lowest figures seen in years, raising concerns about competition [2] - Analysts predict that the companion animal growth rate will need to increase from low- to high-single-digit growth amid rising competition, with estimates around 7% for 2026 [2] - Sales of livestock products declined by 9% on a reported basis, primarily due to the divestiture of the medicated feed additive product portfolio [4] Stock Performance - Following the earnings report, Zoetis stock experienced a decline of 13.14%, trading at $125.39 [3]